Thomas R. Staab II, Senior Vice President and CFO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 3,922 shares at $9.45 ($37K) on 2018-12-04, disclosed to the SEC on 2018-12-06.
Seasonal sale ($37k) by Senior Vice President and CFO — this insider has traded BCRX in December in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| BCRX | SELL | 2019-05-16 | $92K | — | Filing → |
| BCRX | SELL | 2019-05-13 | $224K | — | Filing → |
| BCRX | SELL | 2019-05-06 | $126K | — | Filing → |